PULMONARY VENOUS THROMBOSIS

PULMONARY VENOUS THROMBOSIS was reported 150 times

PULMONARY VENOUS THROMBOSIS is most prevalent among patients taking these drug classes:

# Drug class Count Frequency
0 Dihydrofolate Reductase Inhibitor Antimalarial [EPC] 6 0.0047
1 Sulfonamide Antibacterial [EPC] 1 0.0003
2 Vascular Endothelial Growth Factor Receptor 2 Antagonist [EPC] 1 0.0002
3 Asparagine-specific Enzyme [EPC] 2 0.0001
4 Glinide [EPC] 1 0.0001
5 Programmed Death Receptor-1 Blocking Antibody [EPC] 7 0.0001
6 Purine Antimetabolite [EPC] 7 0.0001
7 Thrombopoietin Receptor Agonist [EPC] 1 0.0001
8 CTLA-4-directed Blocking Antibody [EPC] 3 0.0001
9 Human Immunodeficiency Virus Nucleoside Analog Reverse Transcriptase Inhibitor [EPC] 6 0.0001
10 Orexin Receptor Antagonist [EPC] 1 0.0001
11 Interleukin-17A Antagonist [EPC] 2 0.0001
12 CD52-directed Cytolytic Antibody [EPC] 1 0.0001
13 Vitamin D3 Analog [EPC] 1 0.0000
14 Interleukin-5 Receptor alpha-directed Cytolytic Antibody [EPC] 1 0.0000
15 Human Immunoglobulin G [EPC] 1 0.0000
16 Tetracycline-class Drug [EPC] 3 0.0000
17 Factor Xa Inhibitor [EPC] 10 0.0000
18 Microtubule Inhibitor [EPC] 6 0.0000
19 Iron Chelator [EPC] 1 0.0000
20 Phenothiazine [EPC] 1 0.0000
21 Janus Kinase Inhibitor [EPC] 5 0.0000
22 Dipeptidyl Peptidase 4 Inhibitor [EPC] 1 0.0000
23 Soluble Guanylate Cyclase Stimulator [EPC] 1 0.0000
24 Alkylating Drug [EPC] 7 0.0000
25 Estrogen Receptor Antagonist [EPC] 1 0.0000
26 Proton Pump Inhibitor [EPC] 14 0.0000
27 Calcineurin Inhibitor Immunosuppressant [EPC] 3 0.0000
28 Anti-IgE [EPC] 2 0.0000
29 Amide Local Anesthetic [EPC] 2 0.0000
30 Platinum-based Drug [EPC] 6 0.0000
31 Corticosteroid [EPC] 26 0.0000
32 Antiarrhythmic [EPC] 2 0.0000
33 Ester Local Anesthetic [EPC] 1 0.0000
34 Central alpha-2 Adrenergic Agonist [EPC] 1 0.0000
35 Opioid Agonist [EPC] 5 0.0000
36 Platelet Aggregation Inhibitor [EPC] 10 0.0000
37 Peroxisome Proliferator Receptor alpha Agonist [EPC] 1 0.0000
38 Proteasome Inhibitor [EPC] 2 0.0000
39 Estrogen [EPC] 3 0.0000
40 Antidote [EPC] 1 0.0000
41 Thalidomide Analog [EPC] 8 0.0000
42 Expectorant [EPC] 3 0.0000
43 Osmotic Laxative [EPC] 4 0.0000
44 Atypical Antipsychotic [EPC] 6 0.0000
45 Topoisomerase Inhibitor [EPC] 1 0.0000
46 Non-Standardized Chemical Allergen [EPC] 1 0.0000
47 CD20-directed Cytolytic Antibody [EPC] 4 0.0000
48 Dihydropyridine Calcium Channel Blocker [EPC] 4 0.0000
49 Histamine-1 Receptor Antagonist [EPC] 1 0.0000
50 Integrin Receptor Antagonist [EPC] 1 0.0000
51 Folate Analog Metabolic Inhibitor [EPC] 5 0.0000
52 Progestin [EPC] 3 0.0000
53 RANK Ligand Inhibitor [EPC] 2 0.0000
54 Thiazide Diuretic [EPC] 2 0.0000
55 Nonsteroidal Anti-inflammatory Drug [EPC] 12 0.0000
56 Mood Stabilizer [EPC] 2 0.0000
57 Aromatase Inhibitor [EPC] 1 0.0000
58 P2Y12 Platelet Inhibitor [EPC] 1 0.0000
59 Phosphodiesterase 5 Inhibitor [EPC] 1 0.0000
60 Nucleoside Metabolic Inhibitor [EPC] 2 0.0000
61 alpha-Adrenergic Blocker [EPC] 1 0.0000
62 Leukocyte Growth Factor [EPC] 1 0.0000
63 Calcium [EPC] 1 0.0000
64 beta-Adrenergic Blocker [EPC] 2 0.0000
65 Azole Antifungal [EPC] 1 0.0000
66 Tumor Necrosis Factor Blocker [EPC] 6 0.0000
67 Vascular Endothelial Growth Factor Inhibitor [EPC] 1 0.0000
68 Interferon beta [EPC] 1 0.0000
69 Endothelin Receptor Antagonist [EPC] 1 0.0000
70 Vitamin C [EPC] 2 0.0000
71 Anti-epileptic Agent [EPC] 1 0.0000
72 GLP-1 Receptor Agonist [EPC] 2 0.0000
73 Benzodiazepine [EPC] 3 0.0000
74 Kinase Inhibitor [EPC] 2 0.0000
75 Vitamin D [EPC] 1 0.0000
76 Angiotensin 2 Receptor Blocker [EPC] 1 0.0000
77 Vitamin B12 [EPC] 1 0.0000
78 HMG-CoA Reductase Inhibitor [EPC] 1 0.0000